<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37434760</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1662-4548</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in neuroscience</Title><ISOAbbreviation>Front Neurosci</ISOAbbreviation></Journal><ArticleTitle>Cognitive impairment in post-acute sequelae of COVID-19 and short duration myalgic encephalomyelitis patients is mediated by orthostatic hemodynamic changes.</ArticleTitle><Pagination><StartPage>1203514</StartPage><MedlinePgn>1203514</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1203514</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fnins.2023.1203514</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Cognitive impairment is experienced by people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and post-acute sequelae of COVID-19 (PASC). Patients report difficulty remembering, concentrating, and making decisions. Our objective was to determine whether orthostatic hemodynamic changes were causally linked to cognitive impairment in these diseases.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This prospective, observational cohort study enrolled PASC, ME/CFS, and healthy controls. All participants underwent clinical evaluation and assessment that included brief cognitive testing before and after an orthostatic challenge. Cognitive testing measured cognitive efficiency which is defined as the speed and accuracy of subject's total correct responses per minute. General linear mixed models were used to analyze hemodynamics and cognitive efficiency during the orthostatic challenge. Additionally, mediation analysis was used to determine if hemodynamic instability induced during the orthostatic challenge mediated the relationship between disease status and cognitive impairment.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Of the 276 participants enrolled, 256 were included in this study (34 PASC, 71 &lt;&#x2009;4 year duration ME/CFS, 69 &gt;&#x2009;10 year ME/CFS duration, and 82 healthy controls). Compared to healthy controls, the disease cohorts had significantly lower cognitive efficiency scores immediately following the orthostatic challenge. Cognitive efficiency remained low for the &gt;10 year ME/CFS 2 and 7 days after orthostatic challenge. Narrow pulse pressure less than 25% of systolic pressure occurred at 4 and 5&#x2009;min into the orthostatic challenge for the PASC and ME/CFS cohorts, respectively. Abnormally narrow pulse pressure was associated with slowed information processing in PASC patients compared to healthy controls (-1.5, <i>p</i>&#x2009;=&#x2009;0.04). Furthermore, increased heart rate during the orthostatic challenge was associated with a decreased procedural reaction time in PASC and &lt;&#x2009;4 year ME/CFS patients who were 40 to 65 years of age.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">For PASC patients, both their disease state and hemodynamic changes during orthostatic challenge were associated with slower reaction time and decreased response accuracy during cognitive testing. Reduced cognitive efficiency in &lt;4 year ME/CFS patients was associated with higher heart rate in response to orthostatic stress. Hemodynamic changes did not correlate with cognitive impairment for &gt;10 year ME/CFS patients, but cognitive impairment remained. These findings underscore the need for early diagnosis to mitigate direct hemodynamic and other physiological effects on symptoms of cognitive impairment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Day, Yellman, Hammer, Rond, Bell, Abbaszadeh, Stoddard, Unutmaz, Bateman and Vernon.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Day</LastName><ForeName>Heather</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Medicine, The University of Utah, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yellman</LastName><ForeName>Brayden</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Bateman Horne Center, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammer</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Bateman Horne Center, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rond</LastName><ForeName>Candace</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Bateman Horne Center, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bell</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Bateman Horne Center, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbaszadeh</LastName><ForeName>Saeed</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Bateman Horne Center, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stoddard</LastName><ForeName>Greg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Medicine, The University of Utah, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Unutmaz</LastName><ForeName>Derya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Jackson Laboratory for Genomic Medicine, School of Medicine, University of Connecticut, Farmington, CT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bateman</LastName><ForeName>Lucinda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Bateman Horne Center, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vernon</LastName><ForeName>Suzanne D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Bateman Horne Center, Salt Lake City, UT, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 NS105539</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002538</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UM1 TR004409</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurosci</MedlineTA><NlmUniqueID>101478481</NlmUniqueID><ISSNLinking>1662-453X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ME/CFS</Keyword><Keyword MajorTopicYN="N">cognitive impairment</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN="N">orthostatic hemodynamic changes</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of SARS-CoV-2 (PASC)</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>12</Day><Hour>3</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37434760</ArticleId><ArticleId IdType="pmc">PMC10330752</ArticleId><ArticleId IdType="doi">10.3389/fnins.2023.1203514</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baldwin N. L., Murray K. O., Garcia M. N., Bateman L. (2016). Treatment of postural orthostatic tachycardia syndrome and management of myalgic encephalomyelitis/chronic fatigue syndrome following suspected West Nile virus infection. Fatigue 4, 226&#x2013;236. doi: 10.1080/21641846.2016.1247971</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2016.1247971</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmona-Torre F., M&#xed;nguez-Olaondo A., L&#xf3;pez-Bravo A., Tijero B., Grozeva V., Walcker M., et al. . (2022). Dysautonomia in COVID-19 patients: a narrative review on clinical course, diagnostic and therapeutic strategies. Front. Neurol. 13:886609. doi: 10.3389/fneur.2022.886609</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.886609</ArticleId><ArticleId IdType="pmc">PMC9198643</ArticleId><ArticleId IdType="pubmed">35720084</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J., Jansari V., Hornig M., Iwasaki A. (2022). Unexplained post-acute infection syndromes. Nat. Med. 28, 911&#x2013;923. doi: 10.1038/s41591-022-01810-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciacciarelli A., Sette G., Giubilei F., Orzi F. (2020). Chronic cerebral hypoperfusion: an undefined, relevant entity. J. Clin. Neurosci. 73, 8&#x2013;12. doi: 10.1016/j.jocn.2020.01.026, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2020.01.026</ArticleId><ArticleId IdType="pubmed">31948882</ArticleId></ArticleIdList></Reference><Reference><Citation>Cl&#xe9; M., Eldin P., Briant L., Lannuzel A., Simonin Y., Van de Perre P., et al. . (2020). Neurocognitive impacts of arbovirus infections. J. Neuroinflammation 17:233. doi: 10.1186/s12974-020-01904-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01904-3</ArticleId><ArticleId IdType="pmc">PMC7418199</ArticleId><ArticleId IdType="pubmed">32778106</ArticleId></ArticleIdList></Reference><Reference><Citation>Coffman I., Resnick H. E., Drane J., Lathan C. E. (2018). Computerized cognitive testing norms in active-duty military personnel: potential for contamination by psychologically unhealthy individuals. Appl. Neuropsychol. Adult 25, 497&#x2013;503. doi: 10.1080/23279095.2017.1330749, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23279095.2017.1330749</ArticleId><ArticleId IdType="pubmed">28605213</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook D. B., Light A. R., Light K. C., Broderick G., Shields M. R., Dougherty R. J., et al. . (2017). Neural consequences of post-exertion malaise in Myalgic encephalomyelitis/chronic fatigue syndrome. Brain Behav. Immun. 62, 87&#x2013;99. doi: 10.1016/j.bbi.2017.02.009, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2017.02.009</ArticleId><ArticleId IdType="pubmed">28216087</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H. E., Assaf G. S., McCorkell L., Wei H., Low R. J., Re'em Y., et al. . (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EclinicalMedicine 38:101019. doi: 10.1016/j.eclinm.2021.101019, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaglio C. L., Islam M. F., Cotler J., Jason L. A. (2022). Orthostatic intolerance and neurocognitive impairment in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Epidemiol. Methods 11:20210033. doi: 10.1515/em-2021-0033, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/em-2021-0033</ArticleId><ArticleId IdType="pmc">PMC9550273</ArticleId><ArticleId IdType="pubmed">36310761</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman B. P., Khoury J. A., Blair J. E., Grill M. F. (2021). COVID-19 Dysautonomia. Front. Neurol. 12:624968. doi: 10.3389/fneur.2021.624968, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.624968</ArticleId><ArticleId IdType="pmc">PMC8076737</ArticleId><ArticleId IdType="pubmed">33927679</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I., Davenport T., Wakefield D., Vollmer-Conna U., Cameron B., Vernon S. D., et al. . (2006). Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ 333:575. doi: 10.1136/bmj.38933.585764.AE, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Hingorani K. S., Bhadola S., Cervantes-Arslanian A. M. (2022). COVID-19 and the brain. Trends Cardiovasc. Med. 32, 323&#x2013;330. doi: 10.1016/j.tcm.2022.04.004, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2022.04.004</ArticleId><ArticleId IdType="pmc">PMC9022395</ArticleId><ArticleId IdType="pubmed">35461991</ArticleId></ArticleIdList></Reference><Reference><Citation>Homan TD, Bordes SJ, Cichowski E. Physiology, pulse pressure. Treasure Island, FL: StatPearls Publishing; (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">29494015</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine . Beyond myalgic encephalomyelitis/chronic fatigue syndrome: redefining an illness. Washington, DC: The National Academies; (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25695122</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammoul M., Naddour J., Madi A., Reslan M. A., Hatoum F., Zeineddine J., et al. . (2023). Investigating the possible mechanisms of autonomic dysfunction post-COVID-19. Auton. Neurosci. 245:103071. doi: 10.1016/j.autneu.2022.103071, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2022.103071</ArticleId><ArticleId IdType="pmc">PMC9789535</ArticleId><ArticleId IdType="pubmed">36580747</ArticleId></ArticleIdList></Reference><Reference><Citation>Karemaker J. M. (2017). An introduction into autonomic nervous function. Physiol. Meas. 38, R89&#x2013;R118. doi: 10.1088/1361-6579/aa6782</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/1361-6579/aa6782</ArticleId><ArticleId IdType="pubmed">28304283</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D. B., Pretorius E. (2022). The potential role of ischaemia&#x2013;reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications. Biochem. J. 479, 1653&#x2013;1708. doi: 10.1042/BCJ20220154, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220154</ArticleId><ArticleId IdType="pmc">PMC9484810</ArticleId><ArticleId IdType="pubmed">36043493</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A. L., Bateman L. (2021). Will COVID-19 Lead to Myalgic encephalomyelitis/chronic fatigue syndrome? Front. Med. 7:606824. doi: 10.3389/fmed.2020.606824, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.606824</ArticleId><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A. L., Lipkin W. I. (2021). Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol. Med. 27, 895&#x2013;906. doi: 10.1016/j.molmed.2021.06.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Lathan C., Spira J. L., Bleiberg J., Vice J., Tsao J. W. (2013). Defense automated neurobehavioral assessment (DANA)&#x2014;psychometric properties of a new field-deployable neurocognitive assessment tool. Mil. Med. 178, 365&#x2013;371. doi: 10.7205/MILMED-D-12-00438, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7205/MILMED-D-12-00438</ArticleId><ArticleId IdType="pubmed">23707818</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Vernon S. D., Jeys P., Ali W., Campos A., Unutmaz D., et al. . (2020). Hemodynamics during the 10-minute NASA lean test: evidence of circulatory decompensation in a subset of ME/CFS patients. J. Transl. Med. 18:314. doi: 10.1186/s12967-020-02481-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02481-y</ArticleId><ArticleId IdType="pmc">PMC7429890</ArticleId><ArticleId IdType="pubmed">32799889</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L., O'Boyle S., Palla L., Nacul F. E., Mudie K., Kingdon C. C., et al. . (2020). How Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) progresses: the natural history of ME/CFS. Front. Neurol. 11:826. doi: 10.3389/fneur.2020.00826, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00826</ArticleId><ArticleId IdType="pmc">PMC7431524</ArticleId><ArticleId IdType="pubmed">32849252</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson B. H., Lin J. M. S., Blate M., Khan S., Chen Y., Unger E. R. (2022). Physiological assessment of orthostatic intolerance in chronic fatigue syndrome. J. Transl. Med. 20:95. doi: 10.1186/s12967-022-03289-8, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03289-8</ArticleId><ArticleId IdType="pmc">PMC8849016</ArticleId><ArticleId IdType="pubmed">35172863</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak H., Mohan M. C., Ravindran V. (2019). Chikungunya arthritis. Clin. Med. 19, 381&#x2013;385. doi: 10.7861/clinmed.2019-0035, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2019-0035</ArticleId><ArticleId IdType="pmc">PMC6771335</ArticleId><ArticleId IdType="pubmed">31530685</ArticleId></ArticleIdList></Reference><Reference><Citation>Resnick H. E., Lathan C. E. (2016). From battlefield to home: a mobile platform for assessing brain health. Mhealth. 2:30. doi: 10.21037/mhealth.2016.07.02, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/mhealth.2016.07.02</ArticleId><ArticleId IdType="pmc">PMC5344163</ArticleId><ArticleId IdType="pubmed">28293603</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe P. C. (2002). Orthostatic intolerance and chronic fatigue syndrome: new light on an old problem. J. Pediatr. 140, 387&#x2013;389. doi: 10.1067/mpd.2002.124318, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mpd.2002.124318</ArticleId><ArticleId IdType="pubmed">12006948</ArticleId></ArticleIdList></Reference><Reference><Citation>RStudio Team 
RStudio: integrated development for R. Boston, MA: R. RStudio, PBC, (2020). Available at: http://www.rstudio.com/</Citation></Reference><Reference><Citation>Shan Z. Y., Barnden L. R., Kwiatek R. A., Bhuta S., Hermens D. F., Lagopoulos J. (2020). Neuroimaging characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review. J. Transl. Med. 18:335. doi: 10.1186/s12967-020-02506-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02506-6</ArticleId><ArticleId IdType="pmc">PMC7466519</ArticleId><ArticleId IdType="pubmed">32873297</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigurdsson B. (1956). Clinical findings six years after outbreak of Akureyri disease. Lancet 267, 766&#x2013;767. doi: 10.1016/S0140-6736(56)91236-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(56)91236-3</ArticleId><ArticleId IdType="pubmed">13320872</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigurdsson B., Sigurj&#xf3;nsson J., Sigurdsson J. H., Thorkelsson J., Gudmundsson K. R. (1950). A disease epidemic in Iceland simulating poliomyelitis. Am. J. Epidemiol. 52, 222&#x2013;238. doi: 10.1093/oxfordjournals.aje.a119421, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a119421</ArticleId><ArticleId IdType="pubmed">14771044</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I., Joseph P., Heerdt P. M., Cullinan M., Lutchmansingh D. D., Gulati M., et al. . (2022). Persistent Exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest 161, 54&#x2013;63. doi: 10.1016/j.chest.2021.08.010, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Singhal A. B., Topcuoglu M. A., Koroshetz W. J. (2002). Diffusion MRI in three types of anoxic encephalopathy. J. Neurol. Sci. 196, 37&#x2013;40. doi: 10.1016/S0022-510X(02)00019-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(02)00019-9</ArticleId><ArticleId IdType="pubmed">11959154</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukocheva O. A., Maksoud R., Beeraka N. M., Madhunapantula S. V., Sinelnikov M., Nikolenko V. N., et al. . (2022). Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. J. Adv. Res. 40, 179&#x2013;196. doi: 10.1016/j.jare.2021.11.013, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2021.11.013</ArticleId><ArticleId IdType="pmc">PMC8619886</ArticleId><ArticleId IdType="pubmed">36100326</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C., Verheugt F. W. A., Rowe P. C., Visser F. C. (2020). Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: a quantitative, controlled study using Doppler echography. Clin. Neurophysiol. Pract. 5, 50&#x2013;58. doi: 10.1016/j.cnp.2020.01.003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cnp.2020.01.003</ArticleId><ArticleId IdType="pmc">PMC7044650</ArticleId><ArticleId IdType="pubmed">32140630</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C., Visser F. C. (2022). Psychogenic Pseudosyncope: real or imaginary? Results from a case-control study in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients. Medicina 58:98. doi: 10.3390/medicina58010098</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58010098</ArticleId><ArticleId IdType="pmc">PMC8781940</ArticleId><ArticleId IdType="pubmed">35056406</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon S. D., Funk S., Bateman L., Stoddard G. J., Hammer S., Sullivan K., et al. . (2022). Orthostatic challenge causes distinctive symptomatic, hemodynamic and cognitive responses in long COVID and Myalgic encephalomyelitis/chronic fatigue syndrome. Front. Med. 9:917019. doi: 10.3389/fmed.2022.917019, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.917019</ArticleId><ArticleId IdType="pmc">PMC9285104</ArticleId><ArticleId IdType="pubmed">35847821</ArticleId></ArticleIdList></Reference><Reference><Citation>Walitt B., Johnson T. P. (2022). The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. Curr. Opin. Neurol. 35, 384&#x2013;391. doi: 10.1097/WCO.0000000000001051, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000001051</ArticleId><ArticleId IdType="pmc">PMC9179102</ArticleId><ArticleId IdType="pubmed">35674083</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K. J., Scheibenbogen C., Paul F. (2021). An attempt to explain the neurological symptoms of Myalgic encephalomyelitis/chronic fatigue syndrome. J. Transl. Med. 19:471. doi: 10.1186/s12967-021-03143-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-03143-3</ArticleId><ArticleId IdType="pmc">PMC8607226</ArticleId><ArticleId IdType="pubmed">34809664</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>